Can low zinc and magnesium despite supplementation indicate selective mineral depletion or poor absorption?

Cellular transport and absorption mechanisms

• Shared transport pathways: The divalent cation channel TRPM7 is a crucial intestinal channel; its loss or deficiency directly causes systemic depletion of both zinc and magnesium.
• Transporter interactions: High-dose zinc supplementation (such as 142 mg/day) competitively inhibits intestinal magnesium absorption by competing at non-specific transport sites. Conversely, animal data indicate that magnesium deficiency alters homeostatic cross-talk to enhance intestinal zinc absorption and systemic balance.

Clinical and pathological drivers

• Genetic transport defects: Persistent deficiencies can stem from inherited mutations. Mutations in the SLC39A4 gene (encoding the ZIP4 zinc transporter) cause severe, refractory zinc malabsorption (acrodermatitis enteropathica). Similarly, loss-of-function mutations in TRPM6 cause severe hypomagnesemia with secondary hypocalcemia due to combined intestinal malabsorption and renal wasting.
• Renal and mucosal barriers: Mutations in tight junction proteins claudin-16 or claudin-19 drive renal magnesium wasting (familial hypomagnesemia with hypercalciuria and nephrocalcinosis), leaving serum levels low despite supplementation. Additionally, acquired mucosal disorders like celiac disease and inflammatory bowel disease compromise the intestinal surface area, downregulating active transporter expression for both minerals.

Bottom line

• Concomitant suboptimal zinc and magnesium levels that persist despite active supplementation point to underlying cellular transport defects (such as TRPM7, ZIP4, or TRPM6 dysfunction), renal wasting syndromes, or mucosal malabsorption rather than simple dietary insufficiency.